IN2014MN00880A - - Google Patents
Info
- Publication number
- IN2014MN00880A IN2014MN00880A IN880MUN2014A IN2014MN00880A IN 2014MN00880 A IN2014MN00880 A IN 2014MN00880A IN 880MUN2014 A IN880MUN2014 A IN 880MUN2014A IN 2014MN00880 A IN2014MN00880 A IN 2014MN00880A
- Authority
- IN
- India
- Prior art keywords
- composition
- degrees celsius
- buffer
- viscosity
- mpas
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
- A61K31/025—Halogenated hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
- A61K31/025—Halogenated hydrocarbons carbocyclic
- A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/273,115 US8822549B2 (en) | 2011-10-13 | 2011-10-13 | Buffered oxygen therapeutic |
| PCT/US2012/060284 WO2013056246A1 (en) | 2011-10-13 | 2012-10-15 | Buffered oxygen therapeutic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN00880A true IN2014MN00880A (es) | 2015-04-17 |
Family
ID=48082584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN880MUN2014 IN2014MN00880A (es) | 2011-10-13 | 2012-10-15 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8822549B2 (es) |
| EP (1) | EP2766001B1 (es) |
| JP (3) | JP6117220B2 (es) |
| CN (2) | CN108685882A (es) |
| AU (1) | AU2012323862B2 (es) |
| CA (2) | CA3057480C (es) |
| IN (1) | IN2014MN00880A (es) |
| WO (1) | WO2013056246A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8822549B2 (en) * | 2011-10-13 | 2014-09-02 | Jennifer L. Johnson | Buffered oxygen therapeutic |
| US9700523B2 (en) * | 2011-10-13 | 2017-07-11 | Nuvox Pharma Llc | Buffered oxygen therapeutic |
| US20160206570A1 (en) * | 2013-09-03 | 2016-07-21 | Ariziba Board Of Regents On Behalf Of The University If Arizona | Cardioprotectant to reduce damage from heart attack |
| AU2015227089B2 (en) * | 2014-03-05 | 2019-12-12 | Evan C. Unger | Fractionated radiotherapy and chemotherapy with an oxygen therapeutic |
| CN108697664A (zh) * | 2015-12-21 | 2018-10-23 | 努沃克斯制药有限责任公司 | 氟碳化合物纳米乳液的组合物及其制备方法和用途 |
| CN115814325B (zh) * | 2022-11-23 | 2024-04-19 | 浙江工业大学 | 一种含氟灭火剂组合物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4423077A (en) * | 1982-07-27 | 1983-12-27 | The University Of Pennsylvania | Perfluorochemical emulsion artificial blood |
| US5585112A (en) * | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
| US5656211A (en) * | 1989-12-22 | 1997-08-12 | Imarx Pharmaceutical Corp. | Apparatus and method for making gas-filled vesicles of optimal size |
| US5114932A (en) * | 1990-11-30 | 1992-05-19 | Runge Thomas M | Hyperosmolar oxyreplete hemosubstitute |
| US5196199A (en) * | 1990-12-14 | 1993-03-23 | Fuisz Technologies Ltd. | Hydrophilic form of perfluoro compounds and method of manufacture |
| US5628930A (en) | 1992-10-27 | 1997-05-13 | Alliance Pharmaceutical Corp. | Stabilization of fluorocarbon emulsions |
| US5595687A (en) | 1992-10-30 | 1997-01-21 | Thomas Jefferson University | Emulsion stability |
| NZ262237A (en) | 1993-01-25 | 1997-06-24 | Sonus Pharma Inc | Ultrasound contrast agents comprising phase shift colloids having a boiling point below the body temperature of the animal it is used in |
| US7083572B2 (en) * | 1993-11-30 | 2006-08-01 | Bristol-Myers Squibb Medical Imaging, Inc. | Therapeutic delivery systems |
| US20030032879A1 (en) | 1997-07-07 | 2003-02-13 | Steven Quay | Microbubble formation using ultrasound |
| US7357937B2 (en) * | 2002-09-24 | 2008-04-15 | Therox, Inc. | Perfluorocarbon emulsions with non-fluorinated surfactants |
| WO2010121082A2 (en) | 2009-04-15 | 2010-10-21 | Oxygen Biotherapeutics, Inc. | Emulsions of perfluorocarbons |
| US8822549B2 (en) * | 2011-10-13 | 2014-09-02 | Jennifer L. Johnson | Buffered oxygen therapeutic |
-
2011
- 2011-10-13 US US13/273,115 patent/US8822549B2/en active Active
-
2012
- 2012-10-15 EP EP12839738.7A patent/EP2766001B1/en active Active
- 2012-10-15 WO PCT/US2012/060284 patent/WO2013056246A1/en active Application Filing
- 2012-10-15 IN IN880MUN2014 patent/IN2014MN00880A/en unknown
- 2012-10-15 CN CN201810485100.6A patent/CN108685882A/zh active Pending
- 2012-10-15 AU AU2012323862A patent/AU2012323862B2/en active Active
- 2012-10-15 CA CA3057480A patent/CA3057480C/en active Active
- 2012-10-15 JP JP2014535982A patent/JP6117220B2/ja active Active
- 2012-10-15 CN CN201280057319.7A patent/CN104039317B/zh active Active
- 2012-10-15 CA CA2851522A patent/CA2851522C/en active Active
-
2017
- 2017-03-22 JP JP2017055752A patent/JP6479870B2/ja active Active
-
2019
- 2019-02-06 JP JP2019020091A patent/JP6789328B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014528487A (ja) | 2014-10-27 |
| US20130096204A1 (en) | 2013-04-18 |
| JP6117220B2 (ja) | 2017-04-19 |
| EP2766001C0 (en) | 2024-05-15 |
| WO2013056246A1 (en) | 2013-04-18 |
| JP6789328B2 (ja) | 2020-11-25 |
| CA3057480C (en) | 2021-07-20 |
| CA2851522C (en) | 2019-11-26 |
| EP2766001B1 (en) | 2024-05-15 |
| CN108685882A (zh) | 2018-10-23 |
| US8822549B2 (en) | 2014-09-02 |
| AU2012323862A1 (en) | 2014-05-29 |
| EP2766001A4 (en) | 2015-06-10 |
| CN104039317B (zh) | 2018-05-25 |
| EP2766001A1 (en) | 2014-08-20 |
| CA3057480A1 (en) | 2013-04-18 |
| CA2851522A1 (en) | 2013-04-18 |
| JP6479870B2 (ja) | 2019-03-06 |
| JP2017132789A (ja) | 2017-08-03 |
| JP2019089816A (ja) | 2019-06-13 |
| CN104039317A (zh) | 2014-09-10 |
| AU2012323862B2 (en) | 2015-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120646T1 (el) | Προγονικα κυτταρα μεσοδερμικης προελευσης | |
| PH12015501720A1 (en) | Modulators of methyl modifying enzymes, compositions and uses thereof | |
| IN2014MN00880A (es) | ||
| MX366435B (es) | Papel tisu suave y voluminoso. | |
| MX2013004495A (es) | Microorganismo que produce o-fosfoserina y metodo para producir l-cisteina o derivados de la misma a partir de o-fosfoserina usando los mismos. | |
| MY178142A (en) | Anti-phf-tau antibodies and their uses | |
| MY186864A (en) | Fusion immunomodulatory proteins and methods for making same | |
| MX339059B (es) | Composiciones para el cuidado personal. | |
| TN2013000310A1 (en) | Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections | |
| MX2012007710A (es) | Alfa-amilasas. | |
| MX355295B (es) | Artículos para el cuidado personal. | |
| IN2014DN08721A (es) | ||
| IN2014DN10712A (es) | ||
| MY156851A (en) | Azeotropic and azeotrope-like compositions of methyl perfluoroheptene ethers and trans-1,2-dichloroethylene and uses thereof | |
| EP3039137A4 (en) | Engineered primate cystine/cysteine degrading enzymes as antineogenic agents | |
| IN2014DN10710A (es) | ||
| MX2019003619A (es) | Formulaciones de bromocriptina. | |
| MX354368B (es) | Paño con solucion de polimero en gel para el cuidado personal y la limpieza del hogar. | |
| IN2014DN06104A (es) | ||
| MX356178B (es) | Uso de azucares en matriz de estabilizacion y composiciones solidas. | |
| MY165500A (en) | Use of methylhydroxyethyl cellulose as cement additive | |
| MX2014005854A (es) | Procedimiento de produccion de un cojinete deslizante que comprende un compuesto de cuni2si, cufe2p o cusnx. | |
| MY166879A (en) | Attenuated swine influenza vaccines and methods of making and use thereof | |
| WO2015027160A3 (en) | Allosteric modulators of the cannibinoid 1 receptor | |
| IN2012DN06607A (es) |